Samsung Medison Co., Ltd.

Autophagysciences Inc.

Amorepacific Corporation

Pacific Corporation

Icure

Icure Pharmaceutical Corp.

Yoo Young Pharm. Co. Ltd,

Jung Ju Kim

Suk Jin Lee

Seong-Won Song

Jin Woo Park

Hwan Mook Kim

Kwang Won Jeong

Hyung Min Son

Sun Ki Kim

Jeong A Lee

Sung Soo Kim

Hyeongwan Choi

Hye Jeong Shin

Young Kwen Choi

Yang Gyu Choi

Young So Kim

Seung Hyun Oh

Jung Sik Lee

Sung Ah Bin

Dong Min Lee

Sun Kyoung Kim

Yun Mo Kuk

The present disclosure relates to a novel compound and a pharmaceutical composition comprising the same. The compound according to the present disclosure has effects for activating autophagy, and thus can be valuably used for preventing or treating diseases associated with autophagy regulation.

Compound and pharmaceutical composition comprising same

The present invention relates to a compound represented by Chemical Formula 1 or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of autophagy-related diseases.

Catechol derivative and pharmaceutical composition comprising the same

Embodiments for providing a plurality of 3-dimensional ultrasound images by using a plurality of volume slices in an ultrasound system are disclosed. The ultrasound system comprises: an ultrasound data acquisition unit configured to transmit and receive ultrasound signals to and from a target object to acquire ultrasound data; a volume data forming unit configured to form volume data by using the ultrasound data; a user input unit for allowing a user to input a user instruction; and a processing unit configured to set a plurality of volume slice regions having different widths in the volume data in response to the user instruction and form a plurality of 3-dimensional ultrasound images by using volume slices defined by the volume slice regions.

3-dimensional ultrasound image provision using volume slices in an ultrasound system

Provided is a fentanyl transdermal patch comprising an acrylic-rubber hybrid as a drug-adhesive layer. The fentanyl transdermal patch can maintain constant fentanyl skin permeability for three days by maintaining close contact with the skin such that desorption, release by moisture and sweat, and skin stimulation are all improved.

Fentanyl transdermal patch

Embodiments for providing an ultrasound spatial compound image are disclosed. In one embodiment, by way of non-limiting example, an ultrasound system comprises: an ultrasound data acquisition unit configured to transmit and receive ultrasound signals to and from a target object to output first ultrasound data and a plurality of sets of second ultrasound data corresponding to a region of interest (ROI); a user input unit configured to receive input information for defining the ROI; and a processing unit in communication with the ultrasound data acquisition unit and the user input unit, the processing unit being configured to form volume data based on the plurality of sets of second ultrasound data, compare the first ultrasound data with the volume data to detect geometric information therein, form a two-dimensional (2D) ultrasound image based on the first ultrasound data, and a first three-dimensional (3D) ultrasound image and a second 3D ultrasound data based on the volume data in consideration of the geometric information, and perform a spatial compound upon the 2D ultrasound image, the first 3D ultrasound image and the second 3D ultrasound image based on the geometric information to form an ultrasound spatial compound image.

Providing an ultrasound spatial compound image in an ultrasound system

This invention provides a pharmaceutical composition comprising a lipase inhibitor; a lipophilic oil absorbent selected from the group consisting of hydrogenated castor oil, hydrogenated vegetable oil, glyceryl behenate, glyceryl palmitostearate and a mixture thereof; and a pharmaceutically acceptable additive, an oral formulation of a lipase inhibitor prepared there from and a method for preparing said formulation. The formulation of the present invention can minimize side effects such as oily spotting, fatty/oily stool, abdominal distension and flatus, and thus it can be advantageously used for preventing or treating obesity and hyperlipaemia.

Pharmaceutical composition comprising lipase inhibitor and lipophilic oil absorbent and oral formulation prepared therefrom

The present invention relates to a film-forming agent which forms a film on the skin, and also to a preparation for percutaneous administration containing the film-forming agent and active ingredient. The transdermal preparation including the film-forming agent of the present invention and active ingredient exhibits excellent elasticity and flexibility, shows superior adhesion power when formed on the skin, and forms non-sticky film.

Film-forming agent for drug delivery and preparation for percutaneous administration containing the same

Growing community of inventors

Seoul, South Korea

Jung Ju Kim